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NMDA receptors (NMDARs) are heteromeric assem-
blies of NR1 and NR2(A–D) subunits with properties
heavily influenced by the type of NR2 subunit incor-
porated. While NMDARs with only one type of NR2
subunit have been extensively characterized, little is
known about receptors containing two different NR2
subunits, despite compelling evidence that such tri-
heteromeric receptors exist in vivo. We used a point-
mutation approach that allows isolation of recombinant
triheteromeric NMDARs possessing two different NR2
N-terminal domains (NTDs). We show that in recep-
tors associating the NR2A-NTD (sensing nanomolar
Zn) and the NR2B-NTD (sensing ifenprodil), each NTD
binding site retains selective high affinity for its li-
gand. However, each ligand produces only partial in-
hibition, and maximal inhibition requires occupancy
of both NR2-NTDs by their respective ligands. Simi-
larly, NR1/2A/2C receptors are inhibited by zinc with
high potency but low efficacy. Therefore, interactions
between homologous N-terminal domains determine
the unique pharmacological properties of trihetero-
meric NMDARs.
Introduction
N-methyl-D-aspartate (NMDA) receptors are gluta-
mate-gated ion channels that play critical roles in excit-
atory neurotransmission, synaptic plasticity, and neu-
ronal cell death (Dingledine et al., 1999; Kemp and
McKernan, 2002). Early patch-clamp and binding ex-
periments on neurons revealed that native NMDARs do
not exist as a single, functionally homogenous popula-
tion of receptors, but rather as distinct subtypes dis-
playing both regional and developmental variability in
their agonist sensitivities, activation kinetics, sensitivity
to allosteric modulators, and permeation properties. It
is now well established that this functional diversity is
generated by differential incorporation of various types
of subunits (for review, see Dingledine et al., 1999; Cull-
Candy et al., 2001). NMDARs function as heteromeric
assemblies associating NR1 and NR2 subunits, and,
less commonly, NR3 subunits. The NR1 subunit, ubiqui-
tously expressed in the CNS, is encoded by a single
gene but occurs as eight distinct isoforms as a result
of alternative splicing. The NR2 subunits are encoded
by four different genes (NR2A –NR2D) and have distinct*Correspondence: paoletti@biologie.ens.frdistributions in the CNS, with patterns of expression
that change strikingly during development. In the em-
bryonic brain, NR2B and NR2D subunits predominate,
while NR2A and NR2C are absent. In contrast, in the
adult brain, NR2A predominates, being ubiquitously ex-
pressed, while NR2B expression is restricted to fore-
brain areas, and NR2C is highly enriched in the cerebel-
lum (Watanabe et al., 1992; Ishii et al., 1993; Monyer et
al., 1994).
Functional diversity of native NMDARs is usually as-
sumed to result from the existence of four subpopu-
lations of diheteromeric receptors expressing a simple
binary combination of NR1 and NR2 subunits. However,
as NMDARs are most probably tetramers composed of
two copies of NR1 and two copies of NR2 (see Schorge
and Colquhoun, 2003), functional diversity could also
arise from the incorporation of more than one type of
NR2 subunit in the same receptor complex. In fact,
there is compelling evidence for such heterogeneity in
NR2 subunit assembly. Ternary complexes containing
NR1/2A/2B have been consistently observed in native
tissues, most particularly in the cortex, where they re-
present a sizeable fraction of the NMDA receptor pop-
ulation (Sheng et al., 1994; Didier et al., 1995; Chazot
and Stephenson, 1997; Luo et al., 1997). Other ternary
complexes associating NR2C or NR2D have also been
observed in vivo, most particularly NR1/2A/2C com-
plexes in the cerebellum (Chazot et al., 1994; Sund-
ström et al., 1997; Dunah et al., 1998; Cathala et al.,
2000; Brickley et al., 2003). While diheteromeric NR1/
NR2 receptors have been extensively studied in recom-
binant systems, the functional attributes of trihetero-
meric receptors remain largely unknown.
A striking and distinctive property of the various di-
heteromeric NR1/NR2 receptor subtypes is their dif-
ferential sensitivity to extracellular allosteric modula-
tors, which is commonly used to infer the NR2 subunit
composition of native NMDARs. Thus, NR1/2A recep-
tors are exquisitely sensitive to Zn ions, being inhibited
by low nanomolar concentrations (Williams, 1996;
Paoletti et al., 1997; Chen et al., 1997), while NR1/2B
receptors are selectively antagonized by ifenprodil and
its derivatives, a class of synthetic compounds with
neuroprotectant properties (Williams, 1993). In either
case, inhibition occurs through binding of the modula-
tory ligand (Zn or ifenprodil) to the N-terminal domain
(NTD) of the corresponding NR2 subunit (Choi and Lip-
ton, 1999; Fayyazuddin et al., 2000; Low et al., 2000;
Paoletti et al., 2000; Perin-Dureau et al., 2002). In this
respect, it is unclear whether triheteromeric receptors
associating two different NR2-NTDs are still sensitive
to NR2 subunit-specific ligands.
The paucity of information regarding the function of
triheteromeric receptors results from the fact that ex-
pressing, in recombinant systems, more than one type
of NR2 subunit yields a mixture of receptor populations
(diheteromeric plus triheteromeric receptors) with no
easy way to isolate triheteromeric receptors from the
coexpressed diheteromeric receptors. Here, we use an
approach combining mutagenesis and pharmacology,
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tulations and allows us to study the sensitivity of trihet-





tNMDARs with Only One Active High-Affinity Zn
WBinding Site Retain Zn Sensitivity
1NR1/2A receptors are thought to be composed of two
cNR1 and two NR2A subunits and thus contain two high-
caffinity NR2A-NTD Zn binding sites. We have investi-
tgated whether Zn binding to two such sites is a pre-
mrequisite for nanomolar Zn sensitivity by measuring the
peffects of nanomolar concentrations of Zn on NMDARs
ncontaining only one active NR2A-NTD Zn binding site.
Coexpression of wild-type (wt) NR1, wt NR2A, and a
mutant NR2A subunit defective for Zn binding leads to I
Rthe expression of three receptor populations: a NR1/
2A wt population containing two active NR2A-NTD Zn T
obinding sites, an all mutant NR1/2Amutant population
with both NR2A-NTDs mutated, and a triheteromeric l
tNR1/2A/2Amutant population with only one active NR2A-
NTD Zn binding site per receptor. Investigating the ef- p
Mfect of Zn on the triheteromeric receptor population re-
quires selective elimination of NR1/2A wt receptors, f
rthus leaving triheteromeric receptors the sole remain-
ing population with active NR2A-NTD Zn binding sites. a
wTo this end, we constructed a mutant NR2A subunit
containing two point mutations: H128S, to prevent na- s
tnomolar Zn binding, and N614K, to prevent external Mg
block. H128, located in the NR2A-NTD, is thought to c
tdirectly participate in Zn coordination, and its mutation
to serine produces a 520-fold reduction in Zn sensitivity r
L(Fayyazuddin et al., 2000; Paoletti et al., 2000). N614,
located at the tip of the M2 loop, is a key determinant
pof Mg sensitivity, and its mutation to positively charged
residues abolishes Mg block (Wollmuth et al., 1998) 6
o(Figure 1B).
Xenopus oocytes expressing diheteromeric NR1/ m
s2AH128SN614K receptors elicited inward currents at −80
mV in response to application of 100 M glutamate and s
eglycine. These currents were almost unaffected (4.0% ±
0.9% inhibition, n = 8 cells) by the application of 1 mM e
mMg or by additional application of 200 nM Zn (3.9% ±
0.4% inhibition, n = 8 cells; Figure 1B). In contrast, t
lNMDA currents in cells expressing NR1/2A wt recep-
tors were virtually abolished in 1mM Mg (99.2% ± 0.3% t
(inhibition, n = 9 cells; Figure 1A). Although not evident
at −80 mV, additional application of 200 nM Zn also pro- (
gduces a strong inhibition of NR1/2A wt receptors, as
revealed in voltage ramps from −100 to +50 mV (Figure v
c1A). We confirmed this observation in steady-state re-
cordings in Mg at −30 mV (a potential at which Mg n
lblock is not complete), which revealed 73.1% ± 1.2%
(n = 3 cells, data not shown) inhibition by Zn (200 nM). s
dFurther, NR1/2AN614K receptors, which are insensitive
to Mg block, showed a similar 64.2% ± 3.2% (n = 4 s
mcells, data not shown) inhibition by 200 nM Zn (in Mg).
Thus, the effect of nanomolar Zn on NR1/2A receptors n
mappears to be affected neither by the presence of extra-
cellular Mg nor by the presence of the N614K mutation.
mWhen the NR2A subunit is coexpressedH128SN614Klong with both NR1 and NR2A wt subunits, we expect
hat the oocytes will express three populations of
MDARs. As described above, in 1 mM Mg at −80 mV,
he current from NR1/2A wt receptors is almost com-
letely inhibited. Thus, the remaining NMDA receptor
urrent must arise from the Mg-insensitive all mutant
R1/2AH128SN614K receptors, with a possible contribu-
ion from triheteromeric NR1/2A/2AH128SN614K receptors.
hen 200 nM Zn was applied under these conditions,
5.7% ± 1.5% inhibition (n = 9 cells) of the whole-cell
urrents was seen (Figure 1C). As NR1/2AH128N614K re-
eptors are almost unaffected by 200 nM Zn, this inhibi-
ion can only arise from an effect of Zn on the trihetero-
eric NR1/2A/2AH128SN614K population. Thus, NMDARs




o quantify the inhibition by Zn of NMDARs with only
ne active NTD Zn binding site requires functional iso-
ation of a pure triheteromeric NMDA receptor popula-
ion. The dual point-mutation approach used above
ermits the elimination of NR1/2A wt receptors with
g, but does not allow us to separate the contributions
rom triheteromeric and all mutant receptors. To sepa-
ate these two remaining populations, we included an
dditional point mutation in our mutant NR2A subunit,
hich altered glutamate sensitivity. By doing so, we
hould be able to separate triheteromeric and all mu-
ant receptors on a glutamate concentration-response
urve, with all mutant receptors containing two mu-
ated subunits being further shifted than triheteromeric
eceptors containing only one mutant subunit (see
aube et al., 1998).
One mutation that appeared interesting for our pur-
oses was a threonine to alanine mutation at position
90 in the glutamate binding site, which induces a shift
f w1000-fold in the glutamate EC50 without affecting
aximum current level (Anson et al., 1998). Further,
ingle-channel analysis revealed that this mutation
trongly affects glutamate binding, but has very little
ffect on channel gating (Anson et al., 2000). Structural
vidence from the crystallized glutamate binding do-
ain of the AMPA receptor GluR2 supports these func-
ional findings by showing that T655, the GluR2 homo-
og of T690, directly contacts the glutamate molecule
hrough a hydrogen bond with the distal carboxyl group
Armstrong and Gouaux, 2000). As seen by Anson et al.
1998), NR1/2AT690A receptors produced a large shift in
lutamate EC50 compared to wt (EC50 = 2.8 ± 0.1 mM
ersus 4.4 ± 0.2 M), accompanied by a modest
hange in Hill slope (nH = 1.15 ± 0.02 versus 1.33 ± 0.03;
= 4 cells versus n = 9 cells, respectively) (Figure 2A,
eft). According to Laube et al. (1998), the glutamate
ensitivity of T690A-containing receptors should show
ifferent shifts depending on the number of mutant
ubunits per receptor. Unfortunately, the shift in gluta-
ate sensitivity induced by the T690A mutation was
ot sufficient to enable us to separate the trihetero-
eric from all mutant populations (data not shown).
In an attempt to produce a greater shift in the gluta-
ate EC and to better separate the triheteromeric50
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263Figure 1. NR1/2A Receptors with Only One
Active NTD Zn Binding Site Are Zn Sensitive
Schematic representation of NR2 subunit
domains. From top: NTD (blue circle, X for
H128S mutation), glutamate binding site (red
square), and pore domain (single letter code
of the residue at the QRN site; K represents
the Mg-insensitive mutant N614K). Left:
NMDAR currents (−80 mV) in 100 M gluta-
mate and glycine. Application bars indicate
wash in of 1 mM Mg and 200 nM Zn. Right:
currents in response to voltage ramps (−100
to +50 mV) in 100 M glutamate and glycine
(control), after wash in of 1 mM Mg (+Mg),
and after additional wash in of 200 nM Zn
(+Zn).
(A) NR1/2A wt receptors are almost com-
pletely inhibited by Mg at −80 mV, thus
masking any effect of Zn. Ramps show that
high-affinity Zn inhibition becomes evident
at more depolarized potentials where Mg
block is relieved.
(B) All mutant NR1/2AH128SN614K receptors
are barely affected by the application of Mg
or Zn, either at −80 mV or during voltage
ramps.
(C) Currents resulting from coexpression of
all three subunits are mixtures of NR1/2A wt,
all mutant NR1/2AH128SN614K, and trihetero-
meric NR1/2A/2AH128SN614K receptors. At
−80 mV, addition of 1 mM Mg fully inhibits
the wt component (cf. [A]). Additional appli-
cation of Zn now produces further inhibition,
which can only arise from an effect on the
NR1/2A/2AH128S614K receptors.ing this residue to valine, isoleucine, or leucine. The ra- tion, in an attempt to affect glutamate binding to a
Figure 2. Mutations at NR2AT690 Affect Gluta-
mate Sensitivity
(A) Glutamate concentration-response curves
at −80 mV (−60 mV for NR1/2A wt) obtained
from oocytes expressing NR1 and NR2A
subunits. Curves shown, in descending or-
der of potency, are: NR1/2A wt >> NR1/
2AT690V > NR1/2AT690A >> NR1/2AT690I z
NR1/2AT690L. Data are shown fitted with the
Hill equation and normalized to the fitted
maximum. Right panel shows closeup of
concentration-response curves for NR1/
2AT690I and NR1/2AT690L (note y axis scale).
(B) Glutamate concentration-response curves
for T690I containing mutant receptors. No
obvious shift is seen between NR1/
2A N614KT690I or NR1/2A H128SN614KT690I recep-
tors and NR1/2AT690I receptors, indicating
that the H128S and N614K mutations do not
affect glutamate sensitivity. Data were fitted
with the Hill equation (nH fixed = 1) and plot-
ted relative to the response at 1 mM gluta-
mate. Note that the T690I mutation produces
such a dramatic shift that we can only mea-
sure the foot of the concentration-response
curve. Error bars represent the SEM.and all mutant receptor populations, we introduced
three alternative nonpolar substitutions at T690, mutat-tionale for such substitutions was to increase side
chain length compared to the initial alanine substitu-
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response curves for NR1/2AT690V, 2AT690L, and 2AT690I
receptors are shown in Figure 2. While the T690V muta-
tion induced a slightly smaller shift in glutamate sensi-
tivity than did T690A (EC50 = 1.1 ± 0.02 mM; nH = 1.26 ±
0.01; n = 10), the T690I or T690L mutations produced
huge shifts in glutamate EC50. At 24 hr after injection,
which allows sufficient time for expression of large cur-
rents in cells expressing NR1/2A wt or the T690A or
T690V mutant receptors (0.5–5 A), whole-oocyte cur-
rents from cells expressing NR1/2AT690I or NR1/2AT690L
receptors in response to 10 mM glutamate (plus 100
M glycine) were only on the order of 10–20 nA. Only
after 72 hr was expression sufficient (maximal currents
of several hundred nA at 10 mM glutamate) to permit
estimation of the lower part of the glutamate concen-
tration-response curve. While it is impossible to provide
accurate glutamate EC50s for these two mutations, as
we only have the very foot of the glutamate concentra-
tion-response curve, they are most probably in the mo-
lar range, with estimations being >10 M (nH fixed = 1,
n = 3 [each mutation]). Despite the risk that the T690I
or T690L mutant subunits could act in a negative-domi-
nant manner when incorporated into triheteromeric re- F
iceptors, we combined T690I with the N614K and H128S
Smutations. The resulting NR1/2AN614KT690I and NR1/ n
2AH128SN614KT690I receptors showed sensitivities to glu- c
tamate that were similar to those of the NR1/2AT690I d
receptors (n = 5 each, Figure 2B), indicating that the s
minclusion of the Zn and Mg binding mutations did not
sinterfere with the glutamate binding.
aWhen the NR2AH128SN614KT690I subunit was subse-
fquently coexpressed with wt NR1 and NR2A subunits,
M
the resulting glutamate concentration-response curves h
in zero Mg (24 h after injection) showed only two com- s
ponents, with EC50s of 4.1 ± 0.1 M and 3.0 ± 1.3 mM c
2(relative areas, 72% ± 3% and 28% ± 6%; nH = 1.19 ±
c0.09 and 1.27 ± 0.67; n = 6) (Figure 3). This is to be
rexpected if the contribution to whole-oocyte currents
from the all mutant NR1/2AH128SN614KT690I receptors is
negligible. Indeed, in parallel experiments with cells
Ninjected with only NR1 and NR2AH128SN614KT690I sub- sunits, currents were over 100-fold smaller (at 24 hr) than
lwere those from cells expressing all three
osubunit types, indicating that the likely contribution
nto whole-oocyte currents from the all mutant NR1/
c2AH128SN614KT690I receptors is less than 1%. As expected,
(repeating the glutamate concentration-response curves
in 1 mM Mg virtually abolished the high-affinity (NR1/2A
Qwt) component, leaving an almost pure triheteromeric
wreceptor population with an EC50 corresponding to that
Aof the low-affinity component in the absence of Mg
N(EC50 = 4.0 ± 0.8 mM; relative area, 98% ± 5%; nH =
a0.86 ± 0.06; n = 6).
tExactly the same principle was used to isolate NR1/
i2AN614KT690I/2B or NR1/2AN614KT690I/2C receptors fol-
rlowing coinjection of NR1, NR2AN614KT690I, and NR2B or
MNR2C cDNAs (see Figure S1 in the Supplemental Data
Navailable with this article online). However, we could not
Zentirely suppress the contribution to whole-oocyte cur-
brents from NR1/2C wt receptors with Mg. NMDARs
tcontaining the NR2C subunit are known to be less sen-
wsitive to Mg block than are NR2A- or NR2B-containing
receptors (see Dingledine et al., 1999). In our hands, the cigure 3. Inclusion of the NR2AT690I Mutation Permits Pharmacolog-
cal Isolation of Triheteromeric NMDA Receptors
chematic representation of the three possible NR2 subunit combi-
ations for cells injected with NR1, NR2A, and NR2AH128SN614KT690I
DNAs. Notation is the same as in Figure 1; the T690I mutation is
enoted by an X in the glutamate binding domain. The lower panel
hows glutamate concentration-response curves recorded at −80
V from oocytes expressing NR1, NR2A, and NR2AH128SN614KT690I
ubunits in the absence (■) or presence ($) of 1 mM Mg. The data
re fitted by a two-component Hill equation and normalized to the
itted maximum. Error bars represent the SEM. In the absence of
g, two components are readily distinguished: the first component
as an affinity identical to that of NR1/2A wt receptors, and the
econd has an affinity intermediate between wt and all mutant re-
eptors (see Figure 2) and corresponds to the triheteromeric NR1/
A/2AH128SN614KT690I receptors. In the presence of 1 mM Mg, the wt
omponent is almost completely abolished, so that the residual
eceptor population is almost entirely triheteromeric.R1/2C component was 93.9% ± 0.2% (n = 3, data not
hown) inhibited by 1 mM Mg at −80 mV, but nonethe-
ess still accounted for w14% of the residual whole-
ocyte currents in Mg (Figure S1). Increasing the exter-
al Mg concentration to 3 mM and/or hyperpolarizing
ells to −100 mV did not significantly increase block
n = 3, data not shown).
uantification of Zn Inhibition of NR1/2A NMDARs
ith Only One Active NTD Zn Binding Site
s described above, after coinjection of wt NR1 and
R2A cDNAs along with the NR2AH128SN614KT690I cDNA,
pure triheteromeric NR1/2A/2AH128SN614KT690I recep-
or population with only one active NR2A-NTD Zn bind-
ng site per receptor can be isolated by recording cur-
ents in 10 mM glutamate, 100 M glycine, and 1 mM
g at −80 mV. Under these conditions, triheteromeric
R1/2A/2AH128SN614KT690I receptors were inhibited by
n in a concentration-dependent manner. Notably, inhi-
ition was evident even at low nanomolar concentra-
ions (Figure 4A). The Zn inhibition curve was biphasic,
ith a first high-affinity component in the nanomolar
oncentration range (IC , 28.6 ± 8.1 nM), much like50
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265Figure 4. NR1/2A Receptors with Only One
Active NTD Zn Binding Site Show Nanomolar
Zn Sensitivity
(A) Typical current traces recorded in an
oocyte expressing NR1, NR2A, and
NR2AH128SN614KT690I subunits. Currents at
−80 mV were elicited by application of 10
mM glutamate and 100 M glycine in a
background of 1 mM Mg, to isolate trihetero-
meric NR1/2A/2AH128SN614KT690I receptors.
Currents are shown normalized (before Zn).
The initial current for this cell was 400 nA.
(B) Concentration-response curves showing
Zn inhibition for NR1/2A wt (O), NR1/2A/
2AH128SN614KT690I (■), and NR1/2AH128SN614K
(>) receptors recorded at −80 mV (−30 mV
for NR1/2A wt) in the presence of 1 mM Mg,
100 M glycine, and either 100 M (NR1/2A
and NR1/2AH128SN614K) or 10 mM glutamate
(NR1/2A/2AH128SN614KT690I). NR1/2A/
2AH128SN614KT690I receptors show a biphasic
inhibition with the first component in the nM
range, the extent of which (14%) is interme-
diate between that of NR1/2A wt and NR1/
2AH128SN614K receptors. Data are shown fit-
ted with one- or two-component Hill equa-
tions. Each point represents the average re-
sponse of 3–14 cells. Error bars represent
the SEM. Right panel shows a close-up of the inhibition of triheteromeric receptors in the nM range. Fitted parameters were: NR1/2A: IC50 =
17.6 ± 0.6 nM, nH = 1.06 ± 0.04; NR1/2AH128SN614K: IC50 = 9.0 ± 1.0 M, nH = 0.99 ± 0.13; NR1/2A/2AH128SN614KT690I: IC50s = 28.6 ± 8.1 nM and
5.0 ± 0.9 M, relative areas 17.7% ± 0.2% and 82.3% ± 0.2%, nHs fixed = 1.NR1/2A wt or Mg-insensitive NR1/2AN614K receptors
(IC50, 17.6 ± 0.6 nM and 14.5 ± 2.3 nM, respectively),
presumably reflecting binding to the remaining NR2A-
NTD Zn binding site. The second, lower-affinity compo-
nent shows an affinity similar to that of all mutant NR1/
2AH128SN614K receptors that possess two mutant NTD
binding sites (IC50s, 5.0 ± 0.9 M versus 9.0 ± 1.0 M)
or to that of NR2A-NTD-deleted receptors (IC50, w12
M; Rachline et al., 2005). This low-affinity component
can be accounted for by Zn binding to a non-NTD bind-
ing site common to all NMDA receptor subtypes (Rach-
line et al., 2005). Strikingly, the degree of inhibition as-
sociated with the first component is much reduced
compared to that in NR1/2A wt or NR1/2AN614K recep-
tors. As shown in Figure 4B, in triheteromeric receptors
this high-affinity component of Zn inhibition plateaus at
14.1% ± 0.2% inhibition, compared to 80.4% ± 0.1%
for NR1/2A wt receptors (66.5% ± 4% for NR1/2AN614K).
Thus, although Zn still binds to triheteromeric receptors
with high affinity, the efficacy of inhibition by nanomolar
Zn appears much reduced when only one active NR2A-
NTD Zn binding site is present (see Discussion).
Because we were concerned that the inclusion
of the glutamate binding site mutation might interfere
with NR2-NTD function, we repeated Zn inhibition
curves in Mg on cells expressing NR1, NR2A, and
NR2AH128SN614K subunits devoid of the glutamate muta-
tion (see Figure 1C). This approach was justified by par-
allel experiments indicating that all mutant NR1/
2AH128SN614K receptors yield currents approximately 20-
fold smaller than those for NR1/2A wt (probably due to
a reduced single-channel conductance; see Béhé et al.,
1995). Thus, we believe that, in Mg, the contamination
from all mutant NR1/2AH128SN614K receptors is less than
10%, so that the majority of the current is carried bytriheteromeric NR1/2A/2AH128SN614K receptors. The re-
sulting profile of Zn inhibition was strikingly similar to
that obtained on NR1/2A/2AH128SN614KT690I receptors
(see Figure S2), demonstrating that the inclusion of the
T690I mutation has little effect on Zn inhibition at the
NR2A-NTD.
Zn Sensitivity of Triheteromeric NR1/2A/2C NMDARs
Biochemical and pharmacological evidence supports
the idea that NR1, NR2A, and NR2C subunits can coas-
semble to form triheteromeric NMDARs and that these
receptors are present in the adult cerebellum (Wafford
et al., 1993; Chazot et al., 1994; Cathala et al., 2000).
The functional and modulatory properties of such re-
ceptors remain to be determined. From the perspective
of Zn modulation, this combination is potentially inter-
esting: while the NTD of the NR2A receptor constitutes
a nanomolar affinity Zn binding site, the NTD of the
NR2C subunit does not bind Zn (Rachline et al., 2005).
To assess the possible Zn sensitivity of triheteromeric
NR1/2A/2C receptors, we coexpressed NR1, NR2C,
and NR2AN614KT690I subunits in Xenopus oocytes. The
resulting triheteromeric NR1/2AN614KT690I/2C receptor
population was then functionally isolated within the lim-
its stated above (Figure S1).
As for NR1/2A/2AH128SN614KT690I receptors, NR1/
2AN614KT690I/2C receptor currents showed concentra-
tion-dependent Zn inhibition, evident even in the low
nanomolar range in which NR1/2C receptors are unaf-
fected (Figure 5A). The Zn inhibition curve was bipha-
sic, with an IC50 of 5.6 ± 3.8 nM for the high-affinity
component and a plateau at 28.7% ± 5.0% (Figure 5B).
Thus, in common with NR1/2A/2AH128SN614KT690I recep-
tors, which similarly possess only one active NR2A-
NTD Zn binding site, triheteromeric NR1/2A /N614KT690I
Neuron
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by Nanomolar Zn
(A) Typical current traces from an oocyte ex-
pressing NR1, NR2AN614KT690I, and NR2C
subunits. Currents at −80 mV were elicited
by application of 10 mM glutamate and 100
M glycine in a background of 1 mM Mg to
isolate triheteromeric NR1/2AN614KT690I/2C
receptors. Currents are shown normalized
(before Zn). The initial current for this cell
was 430 nA.
(B) Concentration-response curves showing
Zn inhibition for NR1/2A wt (O), NR1/
2AN614KT690I/2C (■), and NR1/2C wt (>) re-
ceptors recorded at −80 mV for trihetero-
meric receptors or −30 mV for wt receptors
in the presence of 1 mM Mg, 100 M glycine,
and either 100 M (NR1/2A and NR1/2C)
or 10 mM glutamate (NR1/2AN614KT690I/2C).
NR1/2AN614KT690I/2C receptors show a bi-
phasic inhibition, with the first component in
the nM range, reaching a plateau intermedi-
ate between that of NR1/2A and NR1/2C re-
ceptors. Data are shown fitted with one- or
two-component Hill equations. Each point is
the average response of 3–4 cells. Error bars
represent the SEM. The right panel shows a
closeup of the inhibition of triheteromeric re-
ceptors in the nM range. Fitted parameters
were: NR1/2A: as in Figure 4; NR1/2C: IC50 =
15.1 ± 0.9 M, nH = 0.93 ± 0.05; NR1/
2AN614KT690I/2C: IC50s = 5.6 ± 3.8 nM and
10.3 ± 2.9 M, relative areas 28.7% ± 5.0%
and 51.3% ± 2.8%, nHs fixed = 1.2C receptors retain nanomolar Zn sensitivity, but the o
nefficacy of Zn inhibition is much reduced in this con-
centration range compared to that for receptors with f
ttwo NR2A-NTD Zn binding sites.
m
ZZn and Ifenprodil Sensitivity of Triheteromeric
NR1/2A/2B NMDARs b
aThere is compelling biochemical evidence suggesting
that NR1/2A/2B triheteromeric receptors are present in i
pvivo in forebrain neurons (Sheng et al., 1994; Didier et
al., 1995; Chazot and Stephenson, 1997; Luo et al., p
f1997). This raises the possibility that there exists in vivo
a population of Zn- (nanomolar) and ifenprodil-sensitive 2
fNMDARs. Consequently, we expressed NR1, NR2B,
and NR2AN614KT690I subunits in Xenopus oocytes to in- s
pvestigate the modulatory properties of such recep-
tors. As with the other triheteromeric receptors, NR1/ i
f2AN614KT690I/2B receptors were isolated pharmacologi-
cally on the basis of their sensitivities to Mg and gluta- t
Hmate so that modulation of their function by NTD li-
gands could be investigated (see Figure S1). i
fTriheteromeric NR1/2AN614KT690I/2B receptor currents
were inhibited in a concentration-dependent manner by m
Rextracellular Zn (Figure 6A). However, the Zn inhibition
curve, unlike the curves described above, was almost
pequally well fit by either a two- or three-component Hill
equation. The highest-affinity component of the Zn inhi- s
sbition curve had an IC50 of w15 nM, regardless of the
assumptions of the fit, thus revealing an affinity similar o
hto those of NR1/2A wt, NR1/2A/2AH128SN614KT690I, and
NR1/2AN614KT690I/2C receptors, suggesting that the c
uIC reflected Zn binding to the NTD of the NR2A sub-50
unit. As with other triheteromeric receptors, the degreef inhibition associated with this high-affinity compo-
ent (17%–38%, depending on the assumptions of the
it) was reduced compared to that in NR1/2A wt recep-
ors, but it was similar to that seen with other trihetero-
eric receptors containing only one active NR2A-NTD
n binding site. The second intermediate-affinity Zn
inding site was less well defined, but showed a similar
ffinity to that of NR1/2B wt receptors (0.83 ± 0.28 M
n three-component fits or 0.78 ± 0.17 M in two-com-
onent fits versus 0.84 ± 0.03 M for wt). This most
robably reflects Zn binding to the submicromolar af-
inity site located in the NR2B-NTD (Rachline et al.,
005). It should also be noted that in two-component
its, the Hill slope of the second component was very
hallow (nH = 0.6 ± 0.05), indicative of a fit to a mixed
opulation of binding sites, suggesting that there are,
n fact, three different Zn binding sites with different af-
inities in NR1/2AN614KT690I/2B receptors. The fact that
hese curves could be fit by two- or three-component
ill equations probably reflects the difficulty in separat-
ng two Zn binding sites that differ in affinity by only 15-
old (the NR2B-NTD submicromolar site versus the low
icromolar site common to all NMDAR subtypes; see
achline et al., 2005).
Since NR1/2AN614KT690I/2B receptors contain an ifen-
rodil binding site, located on the NTD of the NR2B
ubunit (Perin-Dureau et al., 2002), they should be sen-
itive to ifenprodil as well as to Zn. Indeed, application
f ifenprodil produced a concentration-dependent in-
ibition of such receptors (Figure 6B). In the submi-
romolar range, where NR1/2AN614K receptors are
naffected (IC , 487 ± 24 M), NR1/2A /2B re-50 N614KT690I
ceptors showed a high affinity for ifenprodil (IC50,
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Ifenprodil Sensitive
(A) Concentration-response curves showing
Zn inhibition for NR1/2A wt (>), NR1/
2AN614KT690I/2B (■), and NR1/2B wt (P) re-
ceptors recorded at either −80 mV (trihetero-
meric receptors) or −30 mV (wt receptors) in
the presence of 1 mM Mg, 100 M glycine,
and either 100 M (NR1/2A and NR1/2B)
or 10 mM glutamate (NR1/2AN614KT690I/2B).
NR1/2AN614KT690I/2B receptors show a tri-
phasic inhibition, with the first component in
the low nM range, producing an inhibition in-
termediate between that of NR1/2A and
NR1/2B receptors. Data are shown fitted
with one- or three-component Hill equations.
Each point is the average response of 3–4
cells. The right panel shows a closeup of the
inhibition of triheteromeric receptors in the
nM range. Fitted parameters were: NR1/2A:
as in Figure 4; NR1/2B, IC50 = 0.84 ± 0.03
M, nH = 0.85 ± 0.03; NR1/2AN614KT690I/2B:
IC50s = 15.1 ± 2.7 nM, 0.83 ± 0.28 M, and
3.9 ± 0.4 M, relative areas 38.0% ± 4.6%,
25.8% ± 4.2% and 19.7% ± 5.1%, nHs =
0.78 ± 0.09, 0.89 ± 0.25, and 1.64 ± 0.43. (B)
Left: low M concentrations of ifenprodil
produce a concentration-dependent inhibi-
tion of NR1/2AN614KT690I/2B receptors. Cur-
rents are shown scaled to give the same
response in the absence of ifenprodil. The
initial current for this cell before ifenprodil
application was 720 nA. Right: concentra-
tion-response curves showing ifenprodil in-
hibition for NR1/2B wt (;, +1 mM Mg, −30
mV; O, − Mg, −60 mV), NR1/2AN614KT690I/2B
triheteromeric (■, +1 mM Mg, −80 mV), and
NR1/2AN614K (>, +1 mM Mg, −80 mV) recep-
tors. Glutamate was applied at 100 M
(NR1/2AN614K and NR1/2B) or 10 mM (NR1/
2AN614KT690I/2B). NR1/2AN614KT690I/2B recep-
tors show a biphasic inhibition, with the first
component in the low M range, resulting in
inhibition intermediate between that of NR1/
2B and NR1/2AN614K receptors. Data are
shown fitted with one- or two-component
Hill equations. Each point is the average re-
sponse of 4–9 cells. Fitted parameters were:
NR1/2AN614K: IC50 = 487 ± 24 M, nH = 0.99 ± 0.06; NR1/2B: IC50 = 142 ± 8 nM, nH = 1.0 ± 0.03; NR1/2AN614KT690I/2B: IC50s = 0.80 ± 0.17 M
and 161 ± 24 M, relative areas, 20.6% ± 1.1% and 75.3% ± 1.3%, nHs fixed = 1. (C) Inhibition by Zn and ifenprodil on NR1/2AN614KT690I/2B
receptors is superadditive. Left: ifenprodil added to receptors already inhibited by Zn (black trace) produces an inhibition proportionally
greater than that produced by ifenprodil alone (red trace, scaled accordingly, same oocyte). Right: black bars: average percentage inhibition
by Zn (100 nM) applied alone or on a background of ifenprodil (3 M). Gray bars: inhibition by ifenprodil (3 M) alone or on a background of
Zn (100 nM). Where both inhibitors are present, inhibition by the second inhibitor applied is calculated as the percentage inhibition of the
residual current after application of the first inhibitor. Note that, regardless of the order of application, inhibition by Zn or ifenprodil is greater
in the presence of the complementary inhibitor. Error bars represent the SEM in all cases.0.80 ± 0.17 M), similar to that of NR1/2B wt receptors
(IC50, 142 ± 8 nM, Figure 6B). However, the ifenprodil
inhibition of triheteromeric receptors was biphasic, the
high-affinity component having a plateau at 20.6% ±
1.1% compared to 94.2% ± 1.9% for NR1/2B wt recep-
tors. Thus, as seen for Zn inhibition, it appears that re-
ceptors with only one NR2B-NTD binding site for ifen-
prodil show a modest change in IC50, but a large
change in the extent of inhibition.
Inhibition of Triheteromeric NR1/2A/2B Receptors
by Ifenprodil and Zn Is Superadditive
The observation that triheteromeric receptors with only
one binding site for a particular NTD ligand retain highaffinity but exhibit a low efficacy of inhibition raises the
possibility that when (nanomolar) Zn and ifenprodil are
both applied to NR1/2AN614KT690I/2B receptors, occu-
pation of the two available NR2 NTD sites (Zn on the
NR2AN614KT690I subunit and ifenprodil on the NR2B sub-
unit), will lead to restoration of high-efficacy inhibition.
Figure 6C shows an example of just such an experi-
ment. When 3 M ifenprodil is applied in a background
of 100 nM Zn, the observed inhibition caused by ifen-
prodil is doubled (36.7% ± 2.5% of the residual current)
compared to that with ifenprodil alone (18.5% ± 0.4%).
The same is true if 100 nM Zn is applied in the presence
of 3 M ifenprodil (48% ± 1.8% inhibition compared to
27.7% ± 0.8%, data not shown). The average results
Neuron
268from four cells are shown in Figure 6C (right). Similar e
Nresults were obtained for a range of concentrations of
gZn and ifenprodil (20–100 nM and 1–3 M respectively;
sdata not shown). Thus, it appears that when both NR2-
hNTDs are occupied, the efficacy of inhibition is in-
screased. Interestingly, although these effects are super-
Nadditive, the combined inhibition in the presence of
bboth Zn and ifenprodil is only w55% inhibition. At the
psame concentrations, we would expect w70% inhibi-
dtion of NR1/2A receptors by Zn or w95% inhibition of
NR1/2B receptors by ifenprodil. While the concentra-
stions used are not quite saturating (they were chosen
uto be specific for their respective binding sites), this
rresult does suggest that the maximal inhibition, when
nboth NTDs are occupied, is not as marked for NR1/2A/
n2B receptors as for NR1/2A or NR1/2B receptors.
o
tDistinct Macroscopic Kinetics of Ifenprodil Inhibition
ion Triheteromeric and Wild-Type Receptors
2Because the macroscopic kinetics of ifenprodil inhibi-
ttion of NR2B-containing NMDARs are sufficiently slow
a(τoff, w1 min) that they can be assessed in whole-
moocyte recordings (Williams, 1993; Perin-Dureau et al.,
t2002), we compared the kinetics of ifenprodil inhibition
bon NR1/2B wt and NR1/2AN614KT690I/2B triheteromeric
preceptors. Figure 7A shows typical responses of NR1/
t2B and NR1/2AN614KT690I/2B receptors to 3 M ifen-
tprodil. Not only are triheteromeric receptors much less
oinhibited than are diheteromeric NR1/2B receptors, but
cnormalization of the inhibitions reveals that the kinetics
uof inhibition, and not just the extent, change. The mac-
mroscopic on rate is slower in the triheteromeric recep-
itors, while washout is more rapid (Figures 7B and 7C).
tOn average, the τon was doubled from 3.9 ± 0.3 s (n = t7) in NR1/2B wt to 8.9 ± 0.7 s (n = 11) in triheteromeric
mNR1/2AN614KT690I/2B receptors, while the macroscopic ioff rate (τoff) was slightly more than halved from 78 ± 8 as (n = 4) for NR1/2B to 29 ± 5 s (n = 8) for triheteromeric
breceptors. It is not unexpected that the macroscopic
kinetics of ifenprodil inhibition are distinct for NR1/2A/
t
2B and NR1/2B receptors since the triheteromeric re-
t
ceptors contain only one ifenprodil binding site, while
v
the diheteromers possess two. That τon is slower and t
τoff is faster may reflect differences in the affinity of the p
binding site on the NR2B subunit when paired with an c
NR2A subunit; it may also reflect the change in efficacy (
of single-ligand versus double-ligand closures of NTDs i
(see Discussion). Regardless of the underlying mecha- N
nism, these results reveal that the macroscopic kinetics f





Using an approach based on a combination of point a
mutations, we have been able to functionally isolate re- b
combinant NMDA receptors containing NR1 and two p
different NR2 subunits (triheteromeric receptors). This d
allowed us to establish the functional stoichiometry of a
high-affinity Zn inhibition at NR1/2A receptors and to v
define the sensitivity of triheteromeric NMDA receptors s
to allosteric modulators binding to the NR2-NTDs. We h
ihave unmasked a general rule for NTD function: trihet-romeric assemblies including only one ligand binding
R2-NTD suffices to confer high sensitivity to that li-
and, be it Zn or ifenprodil. Such assemblies, however,
how greatly reduced inhibition compared to their di-
eteromeric counterparts containing two copies of the
ame NR2-NTD. High-efficacy inhibition, as seen on
R1/2A and NR1/2B receptors, requires occupancy of
oth available NR2-NTDs by their respective ligands, a
rinciple applicable even to receptors containing two
ifferent NR2 subunits.
One potential caveat involves our introduction of a
trong glutamate binding mutation into the NR2A sub-
nit, which was necessary to isolate the triheteromeric
eceptor assemblies. Because little is known about the
ature of interactions between the NTDs and the ago-
ist binding domains, NTD ligands may act differently
n our mutated triheteromeric receptors than on native
riheteromeric NMDARs. However, we believe that this
s not the case for the following reasons. First, on NR1/
AN164KT690I/2B receptors, the results of the superaddi-
ivity experiments demonstrate that both NR2-NTDs
re functional despite the presence of the glutamate
utation. Second, either Zn or ifenprodil can inhibit
hese receptors with similar plateaus although the Zn
inds to the glutamate-mutated subunit, whereas ifen-
rodil binds to a wt subunit. Third, and most impor-
antly, we have obtained direct experimental evidence
hat NR2-NTD function is not affected by the presence
f the glutamate binding mutation via recording from
ells expressing NR1, NR2A, and NR2AH128SN614K sub-
nits under conditions of minimal contamination by all
utant receptors (see Figure S2). Zn concentration-
nhibition curves in these cells are almost identical to
hose recorded from NR1/2A/2AH128SN614KT690I recep-
ors. Together, these findings indicate that the T690I-
utation does not affect the ability of NTD ligands to
nhibit NMDARs, suggesting that our current findings
re directly applicable to native triheteromeric assem-
lies.
The discovery that triheteromeric NR1/2A/2B recep-
ors are inhibited by ifenprodil with high affinity, but only
o a limited degree, might explain the apparent contro-
ersy surrounding the sensitivity of NR1/2A/2B recep-
ors to ifenprodil. Kew et al. (1998) suggested that ifen-
rodil-sensitive NR1/2A/2B receptors were present in
ultured cortical neurons, but Tovar and Westbrook
1999) argued against this because they saw only lim-
ted ifenprodil inhibition in HEK-293 cells coexpressing
R1, NR2A, and NR2B subunits. Interpretation of the
indings in either case is complicated by the fact that
hey are based on results from cells expressing mix-
ures of diheteromeric and triheteromeric receptors.
sing a direct biochemical approach, Hawkins et al.
1999) found that in HEK-293 cells transfected with the
R1, NR2A, and NR2B subunits, receptors purified with
n anti-NR2A antibody showed significant high-affinity
inding to the ifenprodil derivative [3H]Ro 25-6981, im-
lying that NR1/2A/2B receptors bind ifenprodil and its
erivatives with high affinity, as suggested by Kew et
l. (1998), but this is apparently at odds with the obser-
ation of Tovar and Westbrook (1999). Our present ob-
ervation that NR1/2AN614KT690I/2B receptors have a
igh affinity for ifenprodil but are inhibited to only a lim-
ted extent ties together these apparently divergent ob-
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269Figure 7. Macroscopic Kinetics of NR1/2A/
2B Triheteromeric and NR1/2B Dihetero-
meric Receptor Inhibition by Ifenprodil Are
Distinct
(A) Typical current traces recorded from oo-
cytes expressing either NR1/2B wt (left) or
NR1/2AN614KT690I/2B triheteromeric recep-
tors (right). Currents were elicited on appli-
cation of either 100 M (NR1/2B) or 10 mM
(NR1/2AN614KT690I/2B) glutamate and 100 M
glycine in a background of 1 mM Mg. Ifen-
prodil (3 M) was applied for the periods in-
dicated by the application bars. Currents
were recorded at either −30 mV (NR1/2B) or
−80 mV (NR1/2AN614KT690I/2B). Note that
NR1/2AN614KT690I/2B receptors are inhibited
to a lesser extent than NR1/2B receptors. (B)
Macroscopic on relaxations (left) and off re-
laxations (right) for the traces shown in (A)
(solid lines). Fits with single exponentials are
superimposed on the experimental results
(dashed gray lines). Traces are shown nor-
malized to the same level of inhibition for
comparison of kinetics. Note that the macro-
scopic on rate for triheteromeric receptors is
slower than that for wt, while the macro-
scopic off rate is more rapid. (C) Scatter plot
of time constants from fitted exponentials to
macroscopic on rates (ton [left]) and off rates
(toff [right]). Open circles show individual re-
sults for NR1/2B and NR1/2AN614KT690I/2B
with n = 7 and n = 11 for ton and n = 4 and
n = 8 for toff, respectively. Horizontal bar in-
dicates the mean of the observed values.servations. Further, our finding that macroscopic on
and off rates of ifenprodil inhibition on these receptors
differ from those on NR1/2B wt receptors may now
serve as a useful tool for detecting the presence of tri-
heteromeric NR1/2A/2B receptors in vivo.
The NR2-NTDs are structurally related to the bacte-
rial protein LIVBP (leucine/isoleucine/valine binding
protein) and to other LIVBP-like domains found in other
membrane receptors, in particular, the agonist binding
domains (ABDs) of metabotropic glutamate and GABA
receptors (Paoletti et al., 2000; Pin et al., 2003). Func-
tional and crystallographic studies of a number of
LIVBP-like domains have revealed that these domains
fold as two lobes separated by a central cleft and that
they oscillate between “open” and “closed” cleft con-
formations, the latter being stabilized upon ligand bind-
ing within the cleft (the “Venus-flytrap” mechanism; see
Pin et al., 2003). Both Zn and ifenprodil act via binding
sites located in the cleft of their respective NR2-NTDs
and are thought to promote cleft closure (Paoletti et al.,
2000; Perin-Dureau et al., 2002). In other words, Zn and
ifenprodil can be considered to be agonists of their re-
spective NTD binding sites, the activation of which
leads to inhibition of the receptor. Exactly how activa-
tion (closure) of the NTDs leads to inhibition of the re-
ceptor is still poorly understood. One suggestion is that
binding of Zn or ifenprodil to the NR2-NTDs induces ashift of the proton sensitivity, rendering the receptors
more sensitive to inhibition by ambient protons (Mott et
al., 1998; Low et al., 2000). In Figure 8, we show two
possible mechanisms for NTD activation that could ac-
count for NR2-NTD inhibition of NMDARs. These pro-
posed mechanisms are based on our knowledge of the
stoichiometry of NMDARs (two NR1 and two NR2 sub-
units) and on our present results. We know that there
are two potential NR2-NTD binding sites per receptor
and that both singly- and doubly-NTD-liganded states
can lead to inhibition, but the degree of inhibition of
the doubly-NTD-liganded receptors is greater (higher
efficacy) than that of singly-NTD-liganded receptors.
What we do not know is whether the NR2-NTDs move
in a concerted fashion (Scheme 1) or independently
(Scheme 2).
In the first case, we assume that the NR2-NTDs can
only change conformation in a concerted manner so
that they are either both open or both closed. The dif-
ference in efficacy of inhibition between singly- and
doubly-NTD-liganded states results from the fact that
the stability of the doubly-NTD-liganded closed state is
greater than that of the singly-NTD-liganded closed
state (efficacy E2 = β2/α2; E1 = β1/α1; E2 > E1). In the
second case, where the NR2-NTDs can move indepen-
dently of one another, inhibition can result from recep-
tors with either one or both NR2-NTDs closed. In this
Neuron
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ceptors via the NR2 NTDs
(A) Two possible reaction schemes for inhibi-
tion of NMDA receptors via the NR2-NTDs.
Both schemes contain two binding steps be-
cause there are probably two NR2-NTDs per
receptor. Because triheteromeric receptors
with only one active site also show inhibition,
we allow for inhibition from both singly- and
doubly-liganded states. Scheme 1 (left) is
based on the assumption that the NTDs can
only move in a concerted manner, while
Scheme 2 (right) is based on the alternative
hypothesis that the NR2-NTDs can move in-
dependently from one another. Paired blue
Venus-flytrap domains represent the NR2-
NTDs in either open or closed states. The
light blue states are the inactive (noninhibit-
ing) states, while the dark blue states are the
active (inhibiting) states. The orange beads
represent NTD agonist molecules. Note that
although the NR2-NTDs are represented as
a dimer for simplicity, we do not know
whether or not they are physically associ-
ated with one another in the intact receptor.
(B) Theoretical Zn concentration-inhibition
curves for three variations on the schemes
shown in (A). Values for parameters were
chosen to give the correct IC50 for wt recep-
tors and the correct degree of inhibition for
wt and triheteromeric receptors. The red
lines (left and right) show a triheteromeric re-
ceptor with only one active binding site
(Scheme 1: states R, AR, and AR**; Scheme
2: states R, AR, and AR*). The blue lines indi-
cate inhibition arising only from the doubly-
liganded, doubly-NTD-closed state (Scheme
1, omission of the state AR**; Scheme 2, only
A2R** is inhibiting). The green lines (repre-
senting the wt scenario) are calculated on
the basis of two sequential bindings with inhibition from both singly- and doubly-liganded receptors, thus giving access to all states. (C)
Theoretical Hill slope-concentration curves for the corresponding concentration-inhibition curves shown in (B). Crosses indicate the IC50 point
for each curve. Note that allowing for singly-liganded inhibition (green lines) results in a shallowing of the Hill slope compared to the case
where only doubly-liganded, doubly-NTD closed receptors cause inhibition (blue lines).scenario, receptors with one open and one closed NR2- t
2NTD have only partial access to the downstream inhibi-
tory machinery, and only receptors with both NR2- t
rNTDs closed have full access (potentially by partial or
full unmasking of a proton sensor). Importantly, in this 2
sscheme singly-NTD-liganded receptors give access
only to the state with partial access to the downstream a
1inhibitory machinery, whereas doubly-NTD-liganded re-
ceptors give access to both singly- and doubly-NTD- 1
Hclosed states, with partial or full access to the inhibi-
tory machinery. t
sUsing parameters chosen to give the correct IC50 for
the wt receptors (18 nM) and correct relative inhibitions c
ofor wt and triheteromeric receptors, the schemes shown
in Figure 8A result in the predicted concentration- p
vinhibition curves and Hill slope-concentration curves
shown in Figures 8B and 8C. Both models predict Zn a
sIC50s for the triheteromeric receptors in the low nano-
molar range, as experimentally observed. Scheme 1 v
Spredicts the correct tendency with regard to the rela-
tive IC50s of wt and triheteromeric receptors, with an r
rIC50 of 25 nM for triheteromeric receptors with only
one active NR2-NTD (red curves), which is very close (o the experimentally determined value for NR1/2A/
AH128SN614KT690I receptors (29 nM). Scheme 2, in con-
rast, predicts an IC50 of 10 nM (red curves), which rep-
esents a shift in the wrong direction. However, Scheme
gives a much better prediction than Scheme 1 of the
hallow Hill slopes, characteristic of high-affinity Zn
nd ifenprodil inhibitions of wt NMDARs (Paoletti et al.,
997; Chen et al., 1997; Kew et al., 1998; Masuko et al.,
999; Perin-Dureau et al., 2002). Scheme 2 predicts a
ill slope of 1.07, very close to the experimentally de-
ermined value (1.06), while Scheme 1 predicts a
teeper slope of 1.33 (see Figure 4 and Figure 8, green
urves,). The shallow Hill slopes initially seem incongru-
us, given the presence of two potential binding sites
er receptor (two NR2 subunits). Our findings now pro-
ide an explanation for this, as both our models predict
shallowing of the concentration-inhibition curve when
ingly-liganded inhibition is taken into account (green
ersus blue lines). Interestingly, evidence that supports
cheme 2 comes from dimeric metabotropic glutamate
eceptors (mGluRs), which possess ABDs structurally
elated to the NTDs of NMDARs. Indeed, Kniazeff et al.
2004) found that in mGluRs, binding of an agonist to
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271both ABDs is required for full activity, but partial activity
can be observed when one ABD is closed by glutamate
while the other is blocked in an open conformation by
an antagonist. For NMDARs, further investigation will
be needed to differentiate between the two models.
One interesting observation from this study was that
while the IC50 for Zn inhibition of the NR1/2A/
2AH128SN614KT690I receptors was very similar to that of
NR1/2A wt receptors, the EC50 for glutamate inhibition
of these triheteromeric receptors was, in contrast, very
different from that of either NR1/2A wt or all mutant
NR1/2AH128SN614KT690I receptors. This suggests that the
interactions between the glutamate binding sites of the
NR2A subunits differ markedly from the interactions at
the level of the NTDs, despite the fact that the two do-
mains share similar bilobate folds and a Venus-flytrap
mechanism (Mayer and Armstrong, 2004). At the level
of the agonist binding sites, it is known that NMDA re-
ceptor gating requires the binding of two molecules of
glutamate and two molecules of glycine (Benveniste
and Mayer, 1991; Clements and Westbrook, 1991).
Again, this is fundamentally different from the effects of
inhibitory agonists of the NR2-NTD in which one ago-
nist molecule is sufficient to produce partial inhibition
(see above). Since all of the agonist binding sites must
be occupied for the channel to open, introducing one
subunit with a mutation that causes a very large shift
in glutamate sensitivity, such as T690I, might prevent
channel activation. That T690I-containing NR2A sub-
units did not act in a negative-dominant manner (see
Figure 3) provides new information about the nature of
the interactions between glutamate binding sites. It
suggests a strong cooperativity between the two gluta-
mate binding sites, such that the site of the T690I-con-
taining subunit increases in affinity when the site of the
wt subunit is occupied. The mechanism of this cooper-
ativity is unknown, but a likely possibility is a direct
physical interaction between glutamate binding do-
mains. This seems a particularly attractive hypothesis,
since isolated glutamate binding domains of AMPA
GluR2 subunits form dimers (Sun et al., 2002) and since
NR1 glycine binding domains have also been sug-
gested to form homodimers (Neugebauer et al., 2003;
but see also Furukawa and Gouaux, 2003). Thus, de-
spite the fact that NTDs fold similarly to the ABDs and
also dimerize (Kuusinen et al., 1999; Ayalon and Stern-
Bach, 2001; Meddows et al., 2001), NTDs and the ABDs
appear to function differently. This could reflect differ-
ences in domain-domain interactions, as the interface
seen in dimeric GluR2 ABDs (Sun et al., 2002) differs
from that seen in dimeric mGluR ABDs (Kunishima et
al., 2000), which are structurally related to the NTD of
ionotropic glutamate receptors. Alternatively, this could
indicate differences in quarternary arrangement, with
homodimers NR1-NR1and NR2-NR2 formed at the level
of the ABDs, but heterodimers NR1-NR2 formed at the
level of the NTDs.
The presence of NR1/2A/2B receptors in adult fore-
brain neurons was demonstrated over ten years ago
(Sheng et al., 1994; see also Didier et al., 1995; Chazot
and Stephenson, 1997; Luo et al., 1997), yet little is
known of their functional properties. Similarly, there is
increasing evidence that triheteromeric NR1/2A/2C re-
ceptors are present in the adult cerebellum (Wafford etal., 1993, Chazot et al., 1994; Cathala et al., 2000). There
is also accumulating evidence that Zn2+ ions, which are
stored and released at many glutamatergic synapses
in the brain, are important endogenous regulators of
NMDA receptor activity (Smart et al., 2004). Basal
Zn levels are thought to provide tonic inhibition of
NMDARs by binding at high-affinity (nanomolar) Zn
binding sites, while synaptically released Zn could pro-
vide phasic inhibition of NMDARs by binding at sites of
lower (micromolar) affinity (see Rachline et al., 2005).
We now demonstrate that both NR1/2A/2B and NR1/
2A/2C receptors retain NR1/2A-like nanomolar Zn sen-
sitivity, which suggests that NR2A-containing trihetero-
meric NMDARs, similarly to NR1/2A receptors, may
also be subject to tonic inhibition at physiological con-
centrations of ambient Zn. However, because the de-
gree of inhibition is reduced compared to diheteromeric
NR1/2A receptors, the regulation of NR2A subunit ex-
pression relative to that of NR2B or NR2C subunits
might provide a way by which cells can fine-tune back-
ground NMDA receptor activity as a function of ambient
Zn concentration. Another striking feature of NR1/2A/
2B receptors is their graded inhibition over a range of
Zn concentrations, spanning almost three orders of
magnitude, from the nanomolar to the micromolar
range. So, unlike NR1/2A receptors, which are strongly
inhibited by tonic (nanomolar) Zn levels, and NR1/2B
receptors, which only sense phasic (micromolar) Zn
(Rachline et al., 2005), triheteromeric NR1/2A/2B recep-
tors could sense both tonic and phasic Zn. Finally, we
find that triheteromeric NR1/2A/2B receptors retain
high-affinity ifenprodil sensitivity, but the degree of inhi-
bition strongly depends on the occupancy of the neigh-
boring NR2A-NTD high-affinity Zn binding site and,
thus, on ambient Zn levels. Since ifenprodil is the proto-
type compound of a family of NR2B-specific antago-
nists with promising neuroprotective properties (Kemp
and McKernan, 2002), this finding could have important
implications for the effects of ifenprodil-like com-
pounds in vivo and their therapeutic potentials.
Experimental Procedures
Molecular Biology
The expression plasmids (for rat NR1-1a, rat NR2A, mouse 2 [re-
ferred to hereafter as NR2B], and rat NR2C), the mutagenesis strat-
egy, and sequencing are as previously described in Paoletti et al.
(1997) and Rachline et al. (2005).
Electrophysiology and Solutions
Xenopus laevis oocytes were isolated, maintained, injected, volt-
age-clamped, and superfused as described by Paoletti et al. (1997).
Oocytes were injected with 30–40 nl of mixtures of wt NR1, wt NR2,
and mutant NR2 cDNAs (10 ng/l) at a ratio of 1:2, NR1:NR2
respectively, for diheteromeric receptors and 1:1:2 for trihetero-
meric NR1/2A/2Amutant and NR1/2B/2Amutant receptors. For NR1/
2C/2Amutant triheteromeric receptors, a ratio of 1:2:1 was injected
to counterbalance the lower expression rate for the NR2C subunit
compared to that for the NR2A subunit. Currents were recorded
after 1–3 days expression with a Warner Instruments OC-725 am-
plifier and filtered at 40 Hz, and data were sampled at 250 Hz with
pClamp 7.0 (Axon Instruments). All experiments were performed at
room temperature (20°C–24°C).
The control solution for superfusion contained: 100 mM NaCl, 5
mM HEPES, 0.3 mM BaCl2, and 10 mM tricine (N-tris[hydroxymeth-
yl]methylglycine, used to chelate trace amounts of contaminating
Zn; Paoletti et al., 1997) (pH, adjusted to 7.3 with KOH). Glycine
Neuron
272and L-glutamate were prepared as 100 mM or 1M aliquots in bidis- o
mtilled water and stored at −20°C. In all experiments, glycine was
applied at 100 M. For applications of 30 mM glutamate-containing
solutions, Na-L-glutamate was dissolved directly in the control so- M
lution and the pH was readjusted accordingly. Ifenprodil (a gift from I
B. Scatton, Sanofi-Sythelabo) was prepared in 50 l aliquots in bi- b
distilled water at 10 mM and stored at −20°C. ZnCl2 stock solutions a
(100 M – 100 mM) were prepared by serial dilutions in bidistilled o
water from an initial stock at 100 mM dissolved in 10−2 N HCl. Zn v
concentration-response curves were obtained using tricine-buf- c
fered Zn solutions (Paoletti et al., 1997). Free Zn concentrations c
were calculated as in Fayyazuddin et al. (2000). For free Zn concen- l
trations of 500 nM or more, the pH of the resulting solution was “
readjusted to 7.3 with NaOH. We did not account for the weak Zn e
chelating properties of solutions containing 100 M glutamate and t
glycine. However, when 10 mM glutamate and 100 M glycine were i
used, plotted free Zn concentrations were adjusted to take into R
account the additional buffering effect of glutamate. The dissoci- S
ation constants for the reaction between Zn and glutamate used in c
Geochem were K1 = 3.2 × 10−7 M and K2 = 3.2 × 10−4 M (Martell c
and Smith, 1982). Note also that in solutions containing 10 mM l
glutamate and 1 mM Mg, Mg chelation by glutamate is negligible N
(Dawson et al., 1986). c
m
aConcentration-Response Curves
For glutamate concentration-response curves (CRCs), the first ago- r
tnist application and every third application thereafter was of a stan-
dard calculated to lie at around the EC30 value. CRCs were con- i
(ducted to either ascending or descending protocols, and currents
for individual cells were plotted relative to their internal standards. k
αFor Zn and ifenprodil CRCs, the agonist solution was first applied
to the oocyte to elicit a maximal current in the presence of Mg, and s
once this current reached steady-state, Zn or ifenprodil was
washed in and inhibition was judged relative to the preceding ago- P
nist-induced current.
Glutamate CRCs were plotted for individual cells and fit with
either single- or multiple-component Hill equations using CVFIT S
(from D. Colquhoun, UCL, London, UK). Individual curves were then S
normalized to their fitted maxima, pooled, and refit with the appro- f
priate Hill equation. In most cases, curves were fitted free, with the f
exception of T690I and T690L, for which only the very base of the
CRC could be estimated, and these were fit with their Hill slopes
fixed to 1. Zn and ifenprodil CRCs were similarly fit with single- A
or multiple-component Hill equations using CVFIT. However, since
inhibition was directly calculated as a percentage decrease in cur- T
rent, data from individual cells could be pooled before fitting. Note (
that for NR1/2A wt receptors, only data %1 M were used for the K
fit. For Zn CRCs on NR1/2AH128SN614K, NR1/2A/2AH128SN614KT690I, a
and NR1/2AN614KT690I/2C receptors, the maximum inhibition was
arbitrarily fixed to 80%, the value obtained from free fits to NR1/2A
wt receptors. This assumption will only affect the second low-affin- R
ity component of the triheteromeric Zn CRCs, which is not the fo- R
cus of the present investigation. Note also that for the trihetero- A
meric receptors, the Hill slopes of the two components were fixed P
to 1. The NR1/2AN614KT690I/2B triheteromeric data were fitted with
either two- or three-component Hill equations, the maximum inhibi- R
tion was left free, and the Hill slopes were fitted either free or fixed
to 1. Ifenprodil CRCs for NR1/2AN614KT690I/2B receptors were fitted A
with maximum inhibition fixed at 96% and the Hill slopes for both R
components fixed to 1. In all cases error bars represent the SEM. t
r
Current-Voltage Relationships A
Current-voltage curves were obtained using slow (2 s) voltage S
ramps from −100 to +50 mV. Capacitive and leakage currents were t
recorded before and after agonist applications, averaged, and sub- 2
tracted from the glutamate-induced current traces using Clampfit
A9.0 (Axon Instruments).
a
sMacroscopic Kinetics of Ifenprodil Inhibition
ABecause the kinetics of ifenprodil inhibition are particularly slow
Aand certainly much slower than the w2 s solution exchange in our
trecording chamber (Perin-Dureau et al., 2002), they can be esti-
mated directly from the current relaxations at the onset and offset Bf ifenprodil applications. The data shown in Figure 7 were esti-
ated with the fitting procedure of Clampfit 9.0.
odeling Inhibition via the NTDs
nhibition was modeled using SCALCS (from D. Colquhoun) on the
asis that Zn is an agonist at the NTD, albeit an agonist that brings
bout a conformational change leading to downstream inhibition
f the NMDA receptor. SCALCS is designed to model channel acti-
ation, whereas we are studying inhibition of the NMDA receptor
hannel. To accommodate this discrepancy, we assumed that the
onformational changes at the level of the NTDs were directly re-
ated to the degree of inhibition, in turn represented as activity at a
channel gate.” The efficacy of inhibition was consequently mod-
led as gating efficacy. Accordingly, the maximal possible activa-
ion (for a channel with a given conductance) equivalent to 100%
nhibition, can be determined by artificially raising E2 to >10,000.
estricted access to the downstream inhibitory machinery in
cheme 2 was modeled as a subconductance state, since it is con-
eptually equivalent to a restricted conformational change at the
hannel gate. We also assumed that the maximum inhibition was
imited by the conformational changes occurring at the level of the
TDs and not by the sensitivity of the downstream inhibitory ma-
hinery. Finally, inhibition is assumed to be independent of gluta-
ate binding. This simplification is justified in view of the fact that,
t NR1/2A receptors, Zn inhibition is roughly constant over a wide
ange of glutamate concentrations (>EC50) (unpublished observa-
ions) and that the likely effectors (protons) have been shown to
nhibit NMDARs independently of the state of agonist ligation
Banke et al., 2005). Parameters used were as follows: Scheme 1:
+ = 1x108 M−1s−1, k− = 2.95 s−1, β1 = β2 = 100 s−1, α1 = 555 s−1,
2 = 25 s−1; Scheme 2: k+ = 1x108 M−1s−1, k− = 8 s−1, β = 101.25
−1, α = 15 s−1.
CVFIT and SCALCS can be obtained from http://www.ucl.ac.uk/
harmacology/dc.html.
upplemental Data
upplemental data include two figures with legends and can be
ound with this article online at http://www.neuron.org/cgi/content/
ull/46/2/261/DC1/.
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